These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34207949)

  • 41. Backbone and side-chain resonance assignments of the NISTmAb-scFv and antigen-binding study.
    Ghasriani H; Ahmadi S; Hodgson DJ; Aubin Y
    Biomol NMR Assign; 2022 Oct; 16(2):391-398. PubMed ID: 36083574
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Backbone 1H, 13C, and 15N resonance assignments of the anti-dansyl antibody Fv fragment.
    Shindo K; Masuda K; Takahashi H; Arata Y; Shimada I
    J Biomol NMR; 2000 Aug; 17(4):357-8. PubMed ID: 11014603
    [No Abstract]   [Full Text] [Related]  

  • 44. Protein NMR Resonance Assignment without Spectral Analysis: 5D SOlid-State Automated Projection SpectroscopY (SO-APSY).
    Orton HW; Stanek J; Schubeis T; Foucaudeau D; Ollier C; Draney AW; Le Marchand T; Cala-De Paepe D; Felli IC; Pierattelli R; Hiller S; Bermel W; Pintacuda G
    Angew Chem Int Ed Engl; 2020 Feb; 59(6):2380-2384. PubMed ID: 31657097
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Production and Characterization of Novel Camel Single Domain Antibody Targeting Mouse Vascular Endothelial Growth Factor.
    Kazemi-Lomedasht F; Behdani M; Habibi-Anbouhi M; Shahbazzadeh D
    Monoclon Antib Immunodiagn Immunother; 2016 Jun; 35(3):167-71. PubMed ID: 27167350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Advances in the study of natural small molecular antibody].
    Zhu L; Zhang DP
    Yao Xue Xue Bao; 2012 Oct; 47(10):1281-6. PubMed ID: 23289139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diversity in kinetics correlated with structure in nano body-stabilized LacY.
    Kumar H; Finer-Moore J; Smirnova I; Kasho V; Pardon E; Steyaert J; Kaback HR; Stroud RM
    PLoS One; 2020; 15(5):e0232846. PubMed ID: 32380514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Structural Effects of Two Camelid Nanobodies Directed to Distinct C-Terminal Epitopes on α-Synuclein.
    El-Turk F; Newby FN; De Genst E; Guilliams T; Sprules T; Mittermaier A; Dobson CM; Vendruscolo M
    Biochemistry; 2016 Jun; 55(22):3116-22. PubMed ID: 27096466
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Exploiting Nanobodies' Singular Traits.
    Ingram JR; Schmidt FI; Ploegh HL
    Annu Rev Immunol; 2018 Apr; 36():695-715. PubMed ID: 29490163
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Change of Amino Acid Residues in Idiotypic Nanobodies Enhanced the Sensitivity of Competitive Enzyme Immunoassay for Mycotoxin Ochratoxin A in Cereals.
    Zhang C; Zhang W; Tang X; Zhang Q; Zhang W; Li P
    Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32340239
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assignment of the side-chain 1H and 13C resonances of interleukin-1 beta using double- and triple-resonance heteronuclear three-dimensional NMR spectroscopy.
    Clore GM; Bax A; Driscoll PC; Wingfield PT; Gronenborn AM
    Biochemistry; 1990 Sep; 29(35):8172-84. PubMed ID: 2261471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Variable fragments of heavy chain antibodies (VHHs): a new magic bullet molecule of medicine?
    Smolarek D; Bertrand O; Czerwinski M
    Postepy Hig Med Dosw (Online); 2012 Jun; 66():348-58. PubMed ID: 22706121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a novel anti-EGFR nanobody by phage display and its distinct paratope and epitope via homology modeling and molecular docking.
    Xi X; Sun W; Su H; Zhang X; Sun F
    Mol Immunol; 2020 Dec; 128():165-174. PubMed ID: 33130376
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nanobody stability engineering by employing the ΔTm shift; a comparison with apparent rate constants of heat-induced aggregation.
    Kunz P; Ortale A; Mücke N; Zinner K; Hoheisel JD
    Protein Eng Des Sel; 2019 Dec; 32(5):241-249. PubMed ID: 31340035
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Engineering an anti-granulocyte colony stimulating factor receptor nanobody for improved affinity.
    Bakherad H; Farahmand M; Setayesh N; Ebrahim-Habibi A
    Life Sci; 2020 Sep; 257():118052. PubMed ID: 32634431
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Institute collection and analysis of Nanobodies (iCAN): a comprehensive database and analysis platform for nanobodies.
    Zuo J; Li J; Zhang R; Xu L; Chen H; Jia X; Su Z; Zhao L; Huang X; Xie W
    BMC Genomics; 2017 Oct; 18(1):797. PubMed ID: 29041922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Automating unambiguous NOE data usage in NVR for NMR protein structure-based assignments.
    Akhmedov M; Çatay B; Apaydın MS
    J Bioinform Comput Biol; 2015 Dec; 13(6):1550020. PubMed ID: 26260854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification and characterization of species-specific nanobodies for the detection of Listeria monocytogenes in milk.
    Tu Z; Chen Q; Li Y; Xiong Y; Xu Y; Hu N; Tao Y
    Anal Biochem; 2016 Jan; 493():1-7. PubMed ID: 26456330
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Exploring cellular biochemistry with nanobodies.
    Cheloha RW; Harmand TJ; Wijne C; Schwartz TU; Ploegh HL
    J Biol Chem; 2020 Nov; 295(45):15307-15327. PubMed ID: 32868455
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.